LSE - Delayed Quote CHF

PolyPeptide Group AG (0AAJ.L)

14.91

+0.33

+(2.26%)

At close: April 14 at 3:32:43 PM GMT+1

PolyPeptide Group AG (XSWX:PPGN) Full Year 2024 Earnings Call Highlights: Strong Commercial ...

PolyPeptide Group AG (XSWX:PPGN) reports a significant EBITDA margin increase and positive free cash flow, setting a strong foundation for future growth.

GuruFocus.com last month

PPGN.SW
Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs

OKLAHOMA CITY & TORRANCE, Calif., January 13, 2025--This new collaboration provides a scalable, integrated solution for developing and manufacturing complex peptide drugs efficiently.

Business Wire 2 months ago

PPGN.SW
Donaldson and PolyPeptide Partner to Improve Sustainability in Peptide Manufacturing with Solvent Recovery Technology

MINNEAPOLIS & TORRANCE, Calif., May 13, 2024--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and PolyPeptide Group AG (SIX: PPGN), a global leader in peptide manufacturing, today announced their collaboration on the development of a production scale solvent recovery system for use in peptide purification. Peptides are used as the active pharmaceutical ingredient (API) in therapeutic areas, which continue to br

Business Wire 10 months ago

PPGN.SW

DCI

Performance Overview

Return	0AAJ.L	MSCI WORLD (^990100-USD-STRD)
YTD	-47.50%	-5.12%
1-Year	-47.07%	+6.04%
3-Year	-81.93%	+18.83%